EDIT
Price
$1.39
Change
+$0.06 (+4.51%)
Updated
May 8 closing price
Capitalization
111.33M
3 days until earnings call
SANA
Price
$1.81
Change
+$0.11 (+6.47%)
Updated
May 8 closing price
Capitalization
383.31M
83 days until earnings call
Ad is loading...

EDIT vs SANA

Header iconEDIT vs SANA Comparison
Open Charts EDIT vs SANABanner chart's image
Editas Medicine
Price$1.39
Change+$0.06 (+4.51%)
Volume$1.95M
Capitalization111.33M
Sana Biotechnology
Price$1.81
Change+$0.11 (+6.47%)
Volume$2.45M
Capitalization383.31M
EDIT vs SANA Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. SANA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and SANA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (EDIT: $1.39 vs. SANA: $1.81)
Brand notoriety: EDIT and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 89% vs. SANA: 76%
Market capitalization -- EDIT: $111.33M vs. SANA: $383.31M
EDIT [@Biotechnology] is valued at $111.33M. SANA’s [@Biotechnology] market capitalization is $383.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 1 green, 4 red.
According to our system of comparison, both EDIT and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 6 bearish.
  • SANA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SANA is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -14.20% price change this week, while SANA (@Biotechnology) price change was -4.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

SANA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($383M) has a higher market cap than EDIT($111M). SANA YTD gains are higher at: 11.043 vs. EDIT (9.449). EDIT has higher annual earnings (EBITDA): -233.11M vs. SANA (-289.51M). EDIT has more cash in the bank: 270M vs. SANA (199M). EDIT has less debt than SANA: EDIT (35M) vs SANA (96.1M). EDIT has higher revenues than SANA: EDIT (32.3M) vs SANA (0).
EDITSANAEDIT / SANA
Capitalization111M383M29%
EBITDA-233.11M-289.51M81%
Gain YTD9.44911.04386%
P/E RatioN/AN/A-
Revenue32.3M0-
Total Cash270M199M136%
Total Debt35M96.1M36%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITSANA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 25 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAEMX14.89N/A
N/A
Parametric Emerging Markets A
NQCAX4.82N/A
N/A
Nuveen Large Cap Value Opportunities A
KSCOX189.64N/A
N/A
Kinetics Small Cap Opportunities No Load
FCCGX22.27N/A
N/A
Fidelity Advisor Small Cap Growth C
SDLAX17.66N/A
N/A
SEI Dynamic Asset Allocation A (SIIT)